{"id":6164,"date":"2023-09-14T08:58:29","date_gmt":"2023-09-14T05:58:29","guid":{"rendered":"https:\/\/www.fez.lt\/?p=6164"},"modified":"2023-09-14T08:58:31","modified_gmt":"2023-09-14T05:58:31","slug":"klaipedos-lez-jav-biotechnologiju-kompanijos-investicija","status":"publish","type":"post","link":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/","title":{"rendered":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Amerikie\u010di\u0173 kapitalo biotechnologij\u0173 bendrov\u0117 \u201eCureline Inc.\u201c investuoja 3,5 mln. Eur \u012f naujos biotechnologij\u0173 gamyklos ir mokslini\u0173 tyrim\u0173 laboratorijos statyb\u0105 Lietuvoje. Gamykla, laboratorija bei administracin\u0117s patalpos \u012fsikurs Klaip\u0117dos LEZ. Veiklos prad\u017eia planuojama 2024 m. pirm\u0105j\u012f pusmet\u012f.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nauj\u0105j\u0105 gamykl\u0105 ir laboratorij\u0105 administruos Lietuvoje \u012fsteigta u\u017edaroji akcin\u0117 bendrov\u0117 \u201eMemel Biotech\u201c, kuri yra \u201eCureline Inc.\u201c grup\u0117s dalis, <a href=\"https:\/\/www.vz.lt\/pramone\/2023\/09\/13\/klaipedos-lez--jav-biotechnologiju-kompanijos-investicija\">skelbia VZ.LT<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Jos vadov\u0117 Agn\u0117 Vaitkevi\u010dien\u0117 teigia, kad bendrov\u0117 u\u017esiims medicinini\u0173 preparat\u0173, \u012fskaitant ir pa\u017eangios terapijos vaistini\u0173 preparat\u0173, gamyba klinikiniams tyrimams, o tiesioginiai klientai bus farmacijos kompanijos bei gydymo \u012fstaigos visame pasaulyje.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201eLietuvoje b\u016bsime pirmieji, galintys sukurti tokio lygio preparatus klinikiniams tyrimams. Taip pat b\u016bsime vieni i\u0161 nedaugelio Baltijos \u0161alyse ir Lenkijoje. \u0160i rinka regione kol kas n\u0117ra pla\u010diai u\u017eimta, ta\u010diau toki\u0173 preparat\u0173 pasaulin\u0117 paklausa yra did\u017eiul\u0117, tod\u0117l ne tik mes, kaip bendrov\u0117, bet ir Lietuva, kaip valstyb\u0117, turi potencial\u0105 tapti pa\u017eangios terapijos technologij\u0173 centru\u201c, \u2013 bendrov\u0117s prane\u0161ime cituojama A. Vaitkevi\u010dien\u0117, UAB \u201eMemel Biotech\u201c generalin\u0117 direktor\u0117.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pasak jos, \u201eMemel Biotech\u201c bus \u012frengtos ir specialios, sterili\u0173 medicinini\u0173 produkt\u0173 gamybos standartus atitinkan\u010dios patalpos, kuriose bus vystomi ir gaminami inovatyv\u016bs biotechnologiniai produktai, skirti personalizuotai medicinai.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Numatomas gamyklos plotas su komercin\u0117mis patalpomis \u2013 850 kv. metr\u0173.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bendrov\u0117 per artimiausius du metus ketina \u012fdarbinti iki 25 auk\u0161tos kvalifikacijos specialist\u0173.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Iki \u0161iol Vilniuje veik\u0117 \u201eCureline Baltic\u201c administracinis biuras ir gyv\u016bn\u0173 laboratorija.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201eM\u016bs\u0173 kompetencija apima ikiklinikinius in vitro, ex vivo ir in vivo modelius, daug d\u0117mesio skiriant ma\u017e\u0173 gyv\u016bn\u0173 tyrimams ir bioanalitin\u0117ms paslaugoms. Glaud\u017eiai bendradarbiaudami su klientais, kuriame individualias ikiklinikini\u0173 tyrim\u0173 strategijas onkologijos, imunologijos, u\u017edegimo, hematologijos, \u0161irdies ir kraujagysli\u0173 lig\u0173, med\u017eiag\u0173 apykaitos, infekcini\u0173 lig\u0173 ir kt. srityse\u201c, \u2013 ra\u0161oma JAV kompanijos interneto svetain\u0117je.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amerikie\u010di\u0173 kapitalo biotechnologij\u0173 bendrov\u0117 \u201eCureline Inc.\u201c investuoja 3,5 mln. Eur \u012f naujos biotechnologij\u0173 gamyklos ir mokslini\u0173 tyrim\u0173 laboratorijos statyb\u0105 Lietuvoje. [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":6162,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1,68,70],"tags":[],"class_list":["post-6164","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-new-investments-developments","category-client-news"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"Amerikie\u010di\u0173 kapitalo biotechnologij\u0173 bendrov\u0117 \u201eCureline Inc.\u201c investuoja 3,5 mln. Eur \u012f naujos biotechnologij\u0173 gamyklos ir mokslini\u0173 tyrim\u0173 laboratorijos statyb\u0105 Lietuvoje. Gamykla, laboratorija bei administracin\u0117s patalpos \u012fsikurs Klaip\u0117dos LEZ. Veiklos prad\u017eia planuojama 2024 m. pirm\u0105j\u012f pusmet\u012f. Nauj\u0105j\u0105 gamykl\u0105 ir laboratorij\u0105 administruos Lietuvoje \u012fsteigta u\u017edaroji akcin\u0117 bendrov\u0117 \u201eMemel Biotech\u201c, kuri yra \u201eCureline Inc.\u201c grup\u0117s dalis, skelbia VZ.LT.\" \/>\n\t<meta name=\"robots\" content=\"noindex, nofollow, max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Kostas Baubinas\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<meta property=\"og:locale\" content=\"lt_LT\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija - Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT\" \/>\n\t\t<meta property=\"og:description\" content=\"Amerikie\u010di\u0173 kapitalo biotechnologij\u0173 bendrov\u0117 \u201eCureline Inc.\u201c investuoja 3,5 mln. Eur \u012f naujos biotechnologij\u0173 gamyklos ir mokslini\u0173 tyrim\u0173 laboratorijos statyb\u0105 Lietuvoje. Gamykla, laboratorija bei administracin\u0117s patalpos \u012fsikurs Klaip\u0117dos LEZ. Veiklos prad\u017eia planuojama 2024 m. pirm\u0105j\u012f pusmet\u012f. Nauj\u0105j\u0105 gamykl\u0105 ir laboratorij\u0105 administruos Lietuvoje \u012fsteigta u\u017edaroji akcin\u0117 bendrov\u0117 \u201eMemel Biotech\u201c, kuri yra \u201eCureline Inc.\u201c grup\u0117s dalis, skelbia VZ.LT.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-09-14T05:58:29+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-09-14T05:58:31+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija - Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Amerikie\u010di\u0173 kapitalo biotechnologij\u0173 bendrov\u0117 \u201eCureline Inc.\u201c investuoja 3,5 mln. Eur \u012f naujos biotechnologij\u0173 gamyklos ir mokslini\u0173 tyrim\u0173 laboratorijos statyb\u0105 Lietuvoje. Gamykla, laboratorija bei administracin\u0117s patalpos \u012fsikurs Klaip\u0117dos LEZ. Veiklos prad\u017eia planuojama 2024 m. pirm\u0105j\u012f pusmet\u012f. Nauj\u0105j\u0105 gamykl\u0105 ir laboratorij\u0105 administruos Lietuvoje \u012fsteigta u\u017edaroji akcin\u0117 bendrov\u0117 \u201eMemel Biotech\u201c, kuri yra \u201eCureline Inc.\u201c grup\u0117s dalis, skelbia VZ.LT.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#blogposting\",\"name\":\"Klaip\\u0117dos LEZ \\u2013 JAV biotechnologij\\u0173 kompanijos investicija - Klaip\\u0117dos Laisvoji Ekonomin\\u0117 Zona | Klaip\\u0117dos LEZ | FEZ.LT\",\"headline\":\"Klaip\\u0117dos LEZ \\u2013 JAV biotechnologij\\u0173 kompanijos investicija\",\"author\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/fez.cpdev.lt\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/LT_WEB_1400x640px-29.jpg\",\"width\":1400,\"height\":640},\"datePublished\":\"2023-09-14T08:58:29+03:00\",\"dateModified\":\"2023-09-14T08:58:31+03:00\",\"inLanguage\":\"lt-LT\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#webpage\"},\"articleSection\":\"All News, NEW INVESTMENTS &amp; DEVELOPMENTS, CLIENT NEWS, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/category\\\/news\\\/#listItem\",\"name\":\"All News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/category\\\/news\\\/#listItem\",\"position\":2,\"name\":\"All News\",\"item\":\"https:\\\/\\\/fez.cpdev.lt\\\/category\\\/news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#listItem\",\"name\":\"Klaip\\u0117dos LEZ \\u2013 JAV biotechnologij\\u0173 kompanijos investicija\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#listItem\",\"position\":3,\"name\":\"Klaip\\u0117dos LEZ \\u2013 JAV biotechnologij\\u0173 kompanijos investicija\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/category\\\/news\\\/#listItem\",\"name\":\"All News\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/#organization\",\"name\":\"Klaip\\u0117dos Laisvoji Ekonomin\\u0117 Zona | Klaip\\u0117dos LEZ | FEZ.LT\",\"url\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/author\\\/admin\\\/\",\"name\":\"Kostas Baubinas\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#webpage\",\"url\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/\",\"name\":\"Klaip\\u0117dos LEZ \\u2013 JAV biotechnologij\\u0173 kompanijos investicija - Klaip\\u0117dos Laisvoji Ekonomin\\u0117 Zona | Klaip\\u0117dos LEZ | FEZ.LT\",\"description\":\"Amerikie\\u010di\\u0173 kapitalo biotechnologij\\u0173 bendrov\\u0117 \\u201eCureline Inc.\\u201c investuoja 3,5 mln. Eur \\u012f naujos biotechnologij\\u0173 gamyklos ir mokslini\\u0173 tyrim\\u0173 laboratorijos statyb\\u0105 Lietuvoje. Gamykla, laboratorija bei administracin\\u0117s patalpos \\u012fsikurs Klaip\\u0117dos LEZ. Veiklos prad\\u017eia planuojama 2024 m. pirm\\u0105j\\u012f pusmet\\u012f. Nauj\\u0105j\\u0105 gamykl\\u0105 ir laboratorij\\u0105 administruos Lietuvoje \\u012fsteigta u\\u017edaroji akcin\\u0117 bendrov\\u0117 \\u201eMemel Biotech\\u201c, kuri yra \\u201eCureline Inc.\\u201c grup\\u0117s dalis, skelbia VZ.LT.\",\"inLanguage\":\"lt-LT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/fez.cpdev.lt\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/LT_WEB_1400x640px-29.jpg\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#mainImage\",\"width\":1400,\"height\":640},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\\\/#mainImage\"},\"datePublished\":\"2023-09-14T08:58:29+03:00\",\"dateModified\":\"2023-09-14T08:58:31+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/#website\",\"url\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/\",\"name\":\"Klaip\\u0117dos Laisvoji Ekonomin\\u0117 Zona | Klaip\\u0117dos LEZ | FEZ.LT\",\"inLanguage\":\"lt-LT\",\"publisher\":{\"@id\":\"https:\\\/\\\/fez.cpdev.lt\\\/lt\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija - Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT","description":"Amerikie\u010di\u0173 kapitalo biotechnologij\u0173 bendrov\u0117 \u201eCureline Inc.\u201c investuoja 3,5 mln. Eur \u012f naujos biotechnologij\u0173 gamyklos ir mokslini\u0173 tyrim\u0173 laboratorijos statyb\u0105 Lietuvoje. Gamykla, laboratorija bei administracin\u0117s patalpos \u012fsikurs Klaip\u0117dos LEZ. Veiklos prad\u017eia planuojama 2024 m. pirm\u0105j\u012f pusmet\u012f. Nauj\u0105j\u0105 gamykl\u0105 ir laboratorij\u0105 administruos Lietuvoje \u012fsteigta u\u017edaroji akcin\u0117 bendrov\u0117 \u201eMemel Biotech\u201c, kuri yra \u201eCureline Inc.\u201c grup\u0117s dalis, skelbia VZ.LT.","canonical_url":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/","robots":"noindex, nofollow, max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#blogposting","name":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija - Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT","headline":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija","author":{"@id":"https:\/\/fez.cpdev.lt\/lt\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/fez.cpdev.lt\/lt\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/fez.cpdev.lt\/wp-content\/uploads\/2023\/09\/LT_WEB_1400x640px-29.jpg","width":1400,"height":640},"datePublished":"2023-09-14T08:58:29+03:00","dateModified":"2023-09-14T08:58:31+03:00","inLanguage":"lt-LT","mainEntityOfPage":{"@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#webpage"},"isPartOf":{"@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#webpage"},"articleSection":"All News, NEW INVESTMENTS &amp; DEVELOPMENTS, CLIENT NEWS, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/fez.cpdev.lt\/lt\/#listItem","position":1,"name":"Home","item":"https:\/\/fez.cpdev.lt\/lt\/","nextItem":{"@type":"ListItem","@id":"https:\/\/fez.cpdev.lt\/category\/news\/#listItem","name":"All News"}},{"@type":"ListItem","@id":"https:\/\/fez.cpdev.lt\/category\/news\/#listItem","position":2,"name":"All News","item":"https:\/\/fez.cpdev.lt\/category\/news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#listItem","name":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija"},"previousItem":{"@type":"ListItem","@id":"https:\/\/fez.cpdev.lt\/lt\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#listItem","position":3,"name":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija","previousItem":{"@type":"ListItem","@id":"https:\/\/fez.cpdev.lt\/category\/news\/#listItem","name":"All News"}}]},{"@type":"Organization","@id":"https:\/\/fez.cpdev.lt\/lt\/#organization","name":"Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT","url":"https:\/\/fez.cpdev.lt\/lt\/"},{"@type":"Person","@id":"https:\/\/fez.cpdev.lt\/lt\/author\/admin\/#author","url":"https:\/\/fez.cpdev.lt\/lt\/author\/admin\/","name":"Kostas Baubinas"},{"@type":"WebPage","@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#webpage","url":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/","name":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija - Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT","description":"Amerikie\u010di\u0173 kapitalo biotechnologij\u0173 bendrov\u0117 \u201eCureline Inc.\u201c investuoja 3,5 mln. Eur \u012f naujos biotechnologij\u0173 gamyklos ir mokslini\u0173 tyrim\u0173 laboratorijos statyb\u0105 Lietuvoje. Gamykla, laboratorija bei administracin\u0117s patalpos \u012fsikurs Klaip\u0117dos LEZ. Veiklos prad\u017eia planuojama 2024 m. pirm\u0105j\u012f pusmet\u012f. Nauj\u0105j\u0105 gamykl\u0105 ir laboratorij\u0105 administruos Lietuvoje \u012fsteigta u\u017edaroji akcin\u0117 bendrov\u0117 \u201eMemel Biotech\u201c, kuri yra \u201eCureline Inc.\u201c grup\u0117s dalis, skelbia VZ.LT.","inLanguage":"lt-LT","isPartOf":{"@id":"https:\/\/fez.cpdev.lt\/lt\/#website"},"breadcrumb":{"@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#breadcrumblist"},"author":{"@id":"https:\/\/fez.cpdev.lt\/lt\/author\/admin\/#author"},"creator":{"@id":"https:\/\/fez.cpdev.lt\/lt\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/fez.cpdev.lt\/wp-content\/uploads\/2023\/09\/LT_WEB_1400x640px-29.jpg","@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#mainImage","width":1400,"height":640},"primaryImageOfPage":{"@id":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/#mainImage"},"datePublished":"2023-09-14T08:58:29+03:00","dateModified":"2023-09-14T08:58:31+03:00"},{"@type":"WebSite","@id":"https:\/\/fez.cpdev.lt\/lt\/#website","url":"https:\/\/fez.cpdev.lt\/lt\/","name":"Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT","inLanguage":"lt-LT","publisher":{"@id":"https:\/\/fez.cpdev.lt\/lt\/#organization"}}]},"og:locale":"lt_LT","og:site_name":"Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT -","og:type":"article","og:title":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija - Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT","og:description":"Amerikie\u010di\u0173 kapitalo biotechnologij\u0173 bendrov\u0117 \u201eCureline Inc.\u201c investuoja 3,5 mln. Eur \u012f naujos biotechnologij\u0173 gamyklos ir mokslini\u0173 tyrim\u0173 laboratorijos statyb\u0105 Lietuvoje. Gamykla, laboratorija bei administracin\u0117s patalpos \u012fsikurs Klaip\u0117dos LEZ. Veiklos prad\u017eia planuojama 2024 m. pirm\u0105j\u012f pusmet\u012f. Nauj\u0105j\u0105 gamykl\u0105 ir laboratorij\u0105 administruos Lietuvoje \u012fsteigta u\u017edaroji akcin\u0117 bendrov\u0117 \u201eMemel Biotech\u201c, kuri yra \u201eCureline Inc.\u201c grup\u0117s dalis, skelbia VZ.LT.","og:url":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/","article:published_time":"2023-09-14T05:58:29+00:00","article:modified_time":"2023-09-14T05:58:31+00:00","twitter:card":"summary_large_image","twitter:title":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija - Klaip\u0117dos Laisvoji Ekonomin\u0117 Zona | Klaip\u0117dos LEZ | FEZ.LT","twitter:description":"Amerikie\u010di\u0173 kapitalo biotechnologij\u0173 bendrov\u0117 \u201eCureline Inc.\u201c investuoja 3,5 mln. Eur \u012f naujos biotechnologij\u0173 gamyklos ir mokslini\u0173 tyrim\u0173 laboratorijos statyb\u0105 Lietuvoje. Gamykla, laboratorija bei administracin\u0117s patalpos \u012fsikurs Klaip\u0117dos LEZ. Veiklos prad\u017eia planuojama 2024 m. pirm\u0105j\u012f pusmet\u012f. Nauj\u0105j\u0105 gamykl\u0105 ir laboratorij\u0105 administruos Lietuvoje \u012fsteigta u\u017edaroji akcin\u0117 bendrov\u0117 \u201eMemel Biotech\u201c, kuri yra \u201eCureline Inc.\u201c grup\u0117s dalis, skelbia VZ.LT."},"aioseo_meta_data":{"post_id":"6164","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-09-14 05:58:31","updated":"2025-08-06 06:19:24","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fez.cpdev.lt\/lt\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fez.cpdev.lt\/category\/news\/\" title=\"All News\">All News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tKlaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/fez.cpdev.lt\/lt\/"},{"label":"All News","link":"https:\/\/fez.cpdev.lt\/category\/news\/"},{"label":"Klaip\u0117dos LEZ \u2013 JAV biotechnologij\u0173 kompanijos investicija","link":"https:\/\/fez.cpdev.lt\/lt\/klaipedos-lez-jav-biotechnologiju-kompanijos-investicija\/"}],"_links":{"self":[{"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/posts\/6164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/comments?post=6164"}],"version-history":[{"count":1,"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/posts\/6164\/revisions"}],"predecessor-version":[{"id":6165,"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/posts\/6164\/revisions\/6165"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/media\/6162"}],"wp:attachment":[{"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/media?parent=6164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/categories?post=6164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fez.cpdev.lt\/lt\/wp-json\/wp\/v2\/tags?post=6164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}